Wordt geladen...
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the developed world and is associated with a fivefold increase in the risk of stroke, accounting for up to 15% of strokes in the general population. The European Society of Cardiology now recommends direct oral anticoagulants, such as...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3968084/ https://ncbi.nlm.nih.gov/pubmed/24711702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S30159 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|